Magainin, Houghten deal

MAGN and HPIP's Multiple Peptide Systems Inc. subsidiary, and the Scripps Resesarch Institute have agreed to a buyout of royalties that MAGN would otherwise have owned on any sales of MSI-78 (Cytolex), a treatment for infection in diabetic foot ulcers. ...